Načítá se...
Genetically engineered mouse models of prostate cancer
Despite major improvement in treatment of early stage localised prostate cancer, the distinction between indolent tumors and those that will become aggressive, as well as the lack of efficient therapies of advanced prostate cancer, remain major health problems. Genetically engineered mice (GEM) have...
Uloženo v:
| Vydáno v: | Mol Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528413/ https://ncbi.nlm.nih.gov/pubmed/23481269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.02.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|